|
Volumn 102, Issue 5, 2010, Pages 359-360
|
Cytoreductive surgery and Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) for gastric adenocarcinoma: Why haven't we reached the promised land?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CAPECITABINE;
CISPLATIN;
EPIRUBICIN;
FLUOROURACIL;
OXALIPLATIN;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURGERY;
CANCER SURVIVAL;
CYTOREDUCTIVE SURGERY;
EDITORIAL;
HUMAN;
PRIORITY JOURNAL;
STOMACH ADENOCARCINOMA;
TREATMENT OUTCOME;
ADENOCARCINOMA;
HYPERTHERMIC THERAPY;
MULTIMODALITY CANCER THERAPY;
PROCEDURES;
REGIONAL PERFUSION;
STOMACH NEOPLASMS;
ADENOCARCINOMA;
CHEMOTHERAPY, CANCER, REGIONAL PERFUSION;
COMBINED MODALITY THERAPY;
HUMANS;
HYPERTHERMIA, INDUCED;
STOMACH NEOPLASMS;
|
EID: 77957326868
PISSN: 00224790
EISSN: 10969098
Source Type: Journal
DOI: 10.1002/jso.21619 Document Type: Editorial |
Times cited : (10)
|
References (8)
|